Facebook to remove false claims about COVID-19 vaccines
The social network said it will remove any Facebook or Instagram posts with false information about COVID-19 vaccines that have been debunked by public health experts.
The social network said it will remove any Facebook or Instagram posts with false information about COVID-19 vaccines that have been debunked by public health experts.
CVS to give free coronavirus antibody drug to eligible patients in pilot program
CVS was picked by the Department of Health and Human Services to give free doses of an antibody drug to eligible coronavirus patients either in their home or long-term care facilities.
CVS was picked by the Department of Health and Human Services to give free doses of an antibody drug to eligible coronavirus patients either in their home or long-term care facilities.
Cuomo announces 170K COVID vaccines to New York by mid-December
Gov. Cuomo says New York State will receive enough COVID-19 vaccines for 170,000 people by the middle of December.
Gov. Cuomo says New York State will receive enough COVID-19 vaccines for 170,000 people by the middle of December.
Dr. Anthony Fauci lays out timetable for when sports fans can return to packed stadiums, arenas
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Disease, laid out a timetable on Monday for when sports teams will likely be able to pack stadiums and arenas again.
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Disease, laid out a timetable on Monday for when sports teams will likely be able to pack stadiums and arenas again.
Britain authorizes COVID vaccine for emergency use
British officials authorized a COVID-19 vaccine for emergency use on Wednesday greenlighting the world’s first shot against the virus.
British officials authorized a COVID-19 vaccine for emergency use on Wednesday greenlighting the world’s first shot against the virus.
Key dates in coronavirus vaccine approval and distribution
Here is a timeline of what to expect in the coming days as U.S. regulators assess COVID-19 vaccines.
Here is a timeline of what to expect in the coming days as U.S. regulators assess COVID-19 vaccines.
FDA chief says agency will get COVID-19 vaccine 'right' amid pressure for rushed release
The head of the agency responsible for authorizing COVID-19 vaccines says federal officials will take the time needed to get the vaccine right.
The head of the agency responsible for authorizing COVID-19 vaccines says federal officials will take the time needed to get the vaccine right.
1st coronavirus vaccines to go to health care workers, nursing homes, US scientific panel votes
The Advisory Committee on Immunization Practices convened a virtual meeting Tuesday to vote on a proposal that would give priority to health care workers and patients in nursing homes and other long-term care facilities.
The Advisory Committee on Immunization Practices convened a virtual meeting Tuesday to vote on a proposal that would give priority to health care workers and patients in nursing homes and other long-term care facilities.
‘We’re not in a good place’: Fauci sounds alarm on COVID-19 pandemic in Facebook interview
The country’s top infectious disease expert Dr. Anthony Fauci took to social media Monday, reiterating that the COVID-19 pandemic is growing worse and affecting younger age groups.
The country’s top infectious disease expert Dr. Anthony Fauci took to social media Monday, reiterating that the COVID-19 pandemic is growing worse and affecting younger age groups.
Americans face new coronavirus restrictions after Thanksgiving
Americans returning from Thanksgiving break faced strict new COVID-19 measures as health officials brace for a worsening of the nationwide surge.
Americans returning from Thanksgiving break faced strict new COVID-19 measures as health officials brace for a worsening of the nationwide surge.
FDA announces advisory committee meeting to discuss Moderna vaccine candidate
The U.S. Food and Drug Administration on Monday announced it has scheduled a meeting this month to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna Inc.
The U.S. Food and Drug Administration on Monday announced it has scheduled a meeting this month to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna Inc.
Red Cross chief: Vaccine 'fake news' is 'second pandemic'
IFRC President Francesco Rocca said in a virtual briefing to the U.N. Correspondents Association that "to beat this pandemic, we also have to defeat the parallel pandemic of distrust."
IFRC President Francesco Rocca said in a virtual briefing to the U.N. Correspondents Association that "to beat this pandemic, we also have to defeat the parallel pandemic of distrust."
Moderna will ask FDA for emergency use authorization of coronavirus vaccine
Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection.
Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection.
As coronavirus vaccine nears, questions linger over who gets it first
As we get closer to a coronavirus vaccine, questions are being raised of who will get it first and how it will be distributed.
As we get closer to a coronavirus vaccine, questions are being raised of who will get it first and how it will be distributed.
Hospitals brace for winter COVID-19 surge as world awaits vaccine
AstraZeneca's announcement of a major discrepancy in its large-scale clinical trials could delay the approval of its vaccine candidate.
AstraZeneca's announcement of a major discrepancy in its large-scale clinical trials could delay the approval of its vaccine candidate.
Thailand, Philippines sign for AstraZeneca COVID-19 vaccine
Thailand on Friday signed a $200 million deal to procure 26 million doses of a trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. It is expected to be delivered in mid-2021.
Thailand on Friday signed a $200 million deal to procure 26 million doses of a trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. It is expected to be delivered in mid-2021.
Americans should be warned of coronavirus vaccine side effects, medical experts say
While promising coronavirus vaccine candidates could aid in bringing the pandemic to its heels, doctors recommended to federal health officials this week that those who eventually receive the long-awaited jab should be wary of the side effects — such as body aches and bad headaches — so they will return for the second dose.
While promising coronavirus vaccine candidates could aid in bringing the pandemic to its heels, doctors recommended to federal health officials this week that those who eventually receive the long-awaited jab should be wary of the side effects — such as body aches and bad headaches — so they will return for the second dose.
A vaccine won't end the COVID-19 crisis right away, experts say
Many challenges lie ahead — not just the logistical hurdles involved in the biggest vaccination campaign in U.S. history, but public fear and misinformation that could hinder the effort and kick the end of the pandemic further down the road.
Many challenges lie ahead — not just the logistical hurdles involved in the biggest vaccination campaign in U.S. history, but public fear and misinformation that could hinder the effort and kick the end of the pandemic further down the road.
Qantas airline plans to require coronavirus vaccine for international travel, CEO says
In a world first, Qantas Airways will likely require passengers to be vaccinated against the coronavirus for future international travel, the CEO announced.
In a world first, Qantas Airways will likely require passengers to be vaccinated against the coronavirus for future international travel, the CEO announced.
AstraZeneca says COVID-19 vaccine 'highly effective' prevention
AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease.
AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease.